Efficacy of methylprednisolone pulse therapy for acute relapse in Japanese patients with multiple sclerosis and neuromyelitis optica: A multicenter retrospective analysis - 1. Whole group analysis

Clinical and Experimental Neuroimmunology

Volumn 4, Issue 3, 2013, Pages 305-317

  Kira, Jun Ichi ^a   Yamasaki, Ryo ^a   Yoshimura, Satoshi ^a   Fukazawa, Toshiyuki ^b   Yokoyama, Kazumasa ^c   Fujihara, Kazuo ^d   Ogino, Mieko ^e   Yokota, Takanori ^f   Miyamoto, Katsuichi ^g   Niino, Masaaki ^b   Nomura, Kyoichi ^h   Tomioka, Ryo ⁱ   Tanaka, Masami ^j   Kawachi, Izumi ^k   Ohashi, Takashi ^l   Kaida, Kenichi ^m   Matsui, Makoto ⁿ   Nakatsuji, Yuji ^o   Ochi, Hirofumi ^p   Fukaura, Hikoaki ^q   Kanda, Takashi ^r   Nagaishi, Akiko ^s   Togo, Kanae ^t   Mizusawa, Hidehiro ^f   Kawano, Yuji ^a   more..

^a KYUSHU UNIVERSITY   (Japan)

^b HOKKAIDO MEDICAL CENTER   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^g KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h SAITAMA MEDICAL UNIVERSITY   (Japan)

ⁱ SAITAMA MEDICAL UNIVERSITY   (Japan)

^j UTANO NATIONAL HOSPITAL   (Japan)

^k NIIGATA UNIVERSITY   (Japan)

^l Tokyo Women s Medical University   (Japan)

^m NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

ⁿ KANAZAWA MEDICAL UNIVERSITY   (Japan)

^o OSAKA UNIVERSITY   (Japan)

^p EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^q IWATE MEDICAL UNIVERSITY   (Japan)

^r YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^s Nagasaki Kawatana Medical Center   (Japan)

^t PFIZER INC   (United States)

more..

Author keywords

corticosteroids; methylprednisolone; multiple sclerosis; neuromyelitis optica; pulse therapy

Indexed keywords

AZATHIOPRINE; BETA INTERFERON; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; HISTAMINE H2 RECEPTOR ANTAGONIST; LAXATIVE; METHOTREXATE; METHYLPREDNISOLONE; MITOXANTRONE; PREDNISOLONE; PROTON PUMP INHIBITOR;

ABDOMINAL DISCOMFORT; ADOLESCENT; ADULT; AGED; AGITATION; ALLERGY; ARTICLE; CEREBELLAR ATAXIA; CHILD; CLINICAL PRACTICE; COMORBIDITY; CONSTIPATION; CORTICOSTEROID THERAPY; DIABETES MELLITUS; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; DYSARTHRIA; DYSPHAGIA; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERREFLEXIA; HYPERTENSION; HYPOKALEMIA; INFECTION; INSOMNIA; JAPAN; JAPANESE; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENTAL DISEASE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NAUSEA; NEUROLOGIC DISEASE; PATHOLOGICAL REFLEX; PLASMAPHERESIS; PNEUMONIA; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCHOOL CHILD; SJOEGREN SYNDROME; THRUSH; TREATMENT RESPONSE; UPPER ABDOMINAL PAIN; URINARY TRACT INFECTION; VASCULAR DISEASE; VERY ELDERLY; YOUNG ADULT;

EID: 84890830651     PISSN: None     EISSN: 17591961     Source Type: Journal    
DOI: 10.1111/cen3.12071     Document Type: Article

References (13)

1. Milligan NM, Newcombe R, Compston DA,. A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects. J Neurol Neurosurg Psychiatry. 1987; 50: 511-6.
2. Thompson AJ, Kennard C, Swash M, Summers B, Yuill GM, Shepherd DI, et al. Relative efficacy of intravenous methylprednisolone and ACTH in the treatment of acute relapse in MS. Neurology. 1989; 39: 969-71.
3. Brusaferri F, Candelise L,. Steroids for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials. J Neurol. 2000; 247: 435-42.
4. Miller DM, Weinstock-Guttman B, Bethoux F, et al. A meta-analysis of methylprednisolone in recovery from multiple sclerosis exacerbations. Mult Scler. 2000; 6: 267-73.
5. Sloka JS, Stefanelli M,. The mechanism of action of methylprednisolone in the treatment of multiple sclerosis. Mult Scler. 2005; 11: 425-32.
6. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004; 364: 2106-12.
7. Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005; 202: 473-7.
8. Sellner J, Boggild M, Clanet M, Hintzen RQ, Illes Z, Montalban X, et al. EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol. 2010; 17: 1019-32.
9. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol. 2005; 58: 840-6.
10. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG,. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006; 66: 1485-9.
11. Kurtzke JF,. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983; 33: 1444-52.
12. Osoegawa M, Kira J, Fukazawa T, Fujihara K, Kikuchi S, Matsui M, et al. Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years. Mult Scler. 2009; 15: 159-73.
13. Shibasaki H, Kuroiwa Y,. Painful tonic seizure in multiple sclerosis. Arch Neurol. 1974; 30: 47-51.